Innate Pharma S.A. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd |
$7.50 | $13.74 M | -0.48 | 23 | $1.61 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.74 | $56.28 M | -5.86 | 2 | $0 |
APM
Aptorum Group Limited |
$1.00 | $22.80 M | -7.1 | 3 | $431,378 |
CSBR
Champions Oncology, Inc. |
$8.28 | $62.53 M | -6.39 | 210 | $50.16 M |
CYAD
Celyad Oncology SA |
$0.47 | $14.24 M | -0.32 | 35 | $102,000 |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
DYAI
Dyadic International, Inc. |
$1.98 | $59.06 M | -7.21 | 7 | $2.90 M |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
HCWB
HCW Biologics Inc. |
$0.42 | $39.35 M | -1.37 | 45 | $2.84 M |
INBX
Inhibrx Biosciences, Inc. |
$14.97 | $241.02 M | -1.44 | 166 | $1.80 M |
IPSC
Century Therapeutics, Inc. |
$1.06 | $244.54 M | -1.32 | 152 | $2.24 M |
MNOV
MediciNova, Inc. |
$2.08 | $67.19 M | -8.06 | 13 | $1.00 M |
MOLN
Molecular Partners AG |
$5.30 | $135.05 M | -2.03 | 167 | $7.04 M |
PRDS
Pardes Biosciences, Inc. |
$2.18 | $135.19 M | -1.7 | 57 | $0 |
STTK
Shattuck Labs, Inc. |
$1.31 | $333.81 M | -3.64 | 75 | $1.66 M |